Eosinophils and antitumour response;Éosinophiles et réponse antitumorale

Revue de Medecine Interne

Volumn 26, Issue 6, 2005, Pages 479-484

  Costello, R ^a   O'Callaghan, T ^a   Sbahoun G ^a  

^a HÔPITAL NORD   (France)

Author keywords

Antitumour response; Eosinophils; Immunotherapy

Indexed keywords

ANTIGEN PRESENTATION; ARTICLE; CANCER CONTROL; CELL PROLIFERATION; CYTOTOXIC T LYMPHOCYTE; EOSINOPHIL; EOSINOPHILIA; HLA SYSTEM; HODGKIN DISEASE; HUMAN; IMMUNITY; PROGNOSIS; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; BIOLOGICAL MODEL; BLOOD; IMMUNOLOGY; NATURAL KILLER CELL; NEOPLASM; REVIEW;

EOSINOPHILIA; EOSINOPHILS; HUMANS; KILLER CELLS, NATURAL; MODELS, IMMUNOLOGICAL; NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 23444439664     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2005.02.013     Document Type: Short Survey

References (36)

1. M. Samoszuk Eosinophils and human cancer Histol. Histopathol. 12 1997 807 812
2. A. Dubost-Brama, S. Dubucquoi, M. Capron, and E. Delaporte Peau et ́osinophiles Encycl. Ḿd. Chir. H́matologie 2001 13-009-A-05
3. L. Prin, M. Lepers, and A.S. Roumier Hypeŕosinophilie et syndromes hypeŕosinophiliques Encycl. Ḿd. Chir. H́matologie 2002 13-009-A-10
4. P.M. Furbert-Harris, K.A. Hunter, T.R. Vaughn, D. Parish-Gause, I. Laniyan, D. Harris, J. Okomo-Awich, K. Forrest, and O.A. Oredipe Eosinophils in a tri-cell multicellular tumor spheroid (MTS)/endothelium complex Cell Mol. Biol. 49 2003 1081 1088
5. P.M. Furbert-Harris, I. Laniyan, D. Harris, G.M. Dunston, T. Vaughn, and A. Abdelnaby Activated eosinophils infiltrate MCF-7 breast multicellular tumor spheroids Anticancer Res. 23 1A 2003 71 78
6. P. Furbert-Harris, D. Parish-Gause, I. Laniyan, K.A. Hunter, J. Okomo-Awich, and T.R. Vaughn Inhibition of prostate cancer cell growth by activated eosinophils Prostate 57 2003 165 175
7. P.M. Furbert-Harris, D. Parish-Gause, K.A. Hunter, T.R. Vaughn, C. Howland, J. Okomo-Awich, K. Forrest, I. Laniyan, A. Abdelnaby, and O.A. Oredipe Activated eosinophils upregulate the metastasis suppressor molecule E-cadherin on prostate tumor cells Cell Mol. Biol. 49 2003 1009 1016
8. S. Ali, J. Kaur, and K.D. Patel Intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation Am. J. Pathol. 157 2000 313 321
9. R.A. Caruso, A. Bersiga, L. Rigoli, and C. Inferrera Eosinophil-tumor cell interaction in advanced gastric carcinoma: an electron microscopic approach Anticancer Res. 22 6C 2002 3833 3836
10. A.L. Stenfeldt, and C. Wenneras Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils Immunology 112 2004 605 614
11. R.T. Costello, C. Fauriat, S. Sivori, E. Marcenaro, and D. Olive NK cells: innate immunity against hematological malignancies? Trends Immunol. 25 2004 328 333
12. S. Kataoka, Y. Konishi, Y. Nishio, K. Fujikawa-Adachi, and A. Tominaga Antitumor activity of eosinophils activated by IL-5 and eotaxin against hepatocellular carcinoma DNA Cell Biol. 23 2004 549 560
13. H.Z. Shi Eosinophils function as antigen-presenting cells J. Leukoc. Biol. 76 2004 520 527
14. R. von Wasielewski, S. Seth, J. Franklin, R. Fischer, K. Hubner, and M.L. Hansmann Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors Blood 95 2000 1207 1213
15. E. Przewoski Ueber die locale eosinophilie beim krebs nebst bemerkungen uber die bedeutung der eosinophilen zellen im allgemeinen Centralbl f Allg Path u Path Anat. 5 1896 177 191
16. A.C. Thompson, P.J. Bradley, and N.R. Griffin Tumor-associated tissue eosinophilia and long-term prognosis for carcinoma of the larynx Am. J. Surg. 168 1994 469 471
17. S.E. Leighton, J.G. Teo, S.F. Leung, A.Y. Cheung, J.C. Lee, and C.A. Van Hasselt Prevalence and prognostic significance of tumor-associated tissue eosinophilia in nasopharyngeal carcinoma Cancer 77 1996 436 440
18. M. Fujii, T. Yamashita, R. Ishiguro, M. Tashiro, and K. Kameyama Significance of epidermal growth factor receptor and tumor associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma Auris Nasus Larynx 29 2002 175 181
19. R.G. Dorta, G. Landman, L.P. Kowalski, J.R. Lauris, M.R. Latorre, and D.T. Oliveira Tumour-associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas Histopathology 41 2002 152 157
20. Y. Ono, M. Ozawa, Y. Tamura, T. Suzuki, K. Suzuki, and K. Kurokawa Tumor-associated tissue eosinophilia of penile cancer Int. J. Urol. 9 2002 82 87
21. H.J. Nielsen, U. Hansen, I.J. Christensen, C.M. Reimert, N. Brunner, and F. Moesgaard Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue J. Pathol. 189 1999 487 495
22. I. Takanami, K. Takeuchi, and M. Gika Immunohistochemical detection of eosinophilic infiltration in pulmonary adenocarcinoma Anticancer Res. 22 2002 2391 2396
23. J. Flamm Tumor-associated tissue inflammatory reaction and eosinophilia in primary superficial bladder cancer Urology 40 1992 180 185
24. G.W. Spiegel Eosinophils as a marker for invasion in vulvar squamous neoplastic lesions Int. J. Gynecol. Pathol. 21 2002 108 116
25. G.W. Spiegel, M. Ashraf, and J.J. Brooks Eosinophils as a marker for invasion in cervical squamous neoplastic lesions Int. J. Gynecol. Pathol. 21 2002 117 124
26. U. Axdorph, A. Porwit-MacDonald, G. Grimfors, and M. Bjorkholm Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease Leuk. Lymphoma 42 2001 1055 1065
27. H. Hanamoto, T. Nakayama, H. Miyazato, S. Takegawa, K. Hieshima, and Y. Tatsumi Expression of CCL28 by Reed-Sternberg cells defines a major subtype of classical Hodgkin's disease with frequent infiltration of eosinophils and/or plasma cells Am. J. Pathol. 164 2004 997 1006
28. D. Molin, B. Glimelius, C. Sundstrom, P. Venge, and G. Enblad The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease Leuk. Lymphoma 42 2001 457 465
29. T. Molina, J. Diebold, and J. Audouin Classification des lymphomes Rev. Prat. 52 2002 951 958
30. L. Rivoltini, V. Viggiano, S. Spinazze, A. Santoro, M.P. Colombo, and K. Takatsu In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5 Int. J. Cancer 54 1993 8 15
31. A. Trulson, S. Nilsson, and P. Venge The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer Br. J. Haematol. 98 1997 312 314
32. M. Moroni, C. Porta, M. De Amici, S. Quaglini, M.A. Cattabiani, and C. Buzio Eosinophils and C4 predict clinical failure of combination immunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patients Haematologica 85 2000 298 303
33. S. Arinaga, N. Karimine, K. Takamuku, S. Nanbara, H. Inoue, and R. Abe Correlation of eosinophilia with clinical response in patients with advanced carcinoma treated with low-dose recombinant interleukin-2 and mitomycin C Cancer Immunol. Immunother. 35 1992 246 250
34. M. Moroni, C. Porta, D. Gritti, M. Di Amici, O. Giacobbe, and E. Bobbio-Pallavicini Cationic protein-rich supernatants of cultured eosinophils from IL-2-treated patients have no cytotoxic activity on human renal cell carcinoma and melanoma cells: a preliminary report Ann. N. Y. Acad. Sci. 832 1997 295 303
35. E. Huland, and H. Huland Tumor-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells J. Cancer Res. Clin. Oncol. 118 1992 463 467
36. S.O. Odemuyiwa, A. Ghabary, Y. Li, L. Puttagunta, J.E. Lee, and S. Musat-Marcu Cutting edge; human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase J. Immunol. 173 2004 5909 5913